ATPC Agape ATP Corporation: Rasio rega marang prakiraan pendapatan

Agape ATP Corporation (ATPC) is optimizing the development of metabolic formulas by outsourcing industrial production to external contractors. The forward price-to-sales ratio visualizes market expectations, where 1.20 expresses the current value of the metric. Rapid sales growth is driven by strong retail distribution. Supply chain stability is guaranteed through the diversification of transport routes and the maintenance of warehouse reserves.

Agape ATP Corp - Rasio kapitalisasi marang dodolan sing dikarepake ATPC (periode 21.02.2024 - 15.11.2026)

Ringkesan rincian data analitis Agape ATP (ATPC)

- rega pasar lan target rega analis:

Bagan rega Agape ATP|ATPC - Rata-rata rega prakiraan

- data kapitalisasi saham perusahaan:

Nilai pasar Agape ATP Corporation|ATPC - Nilai Total Perusahaan

- indikator nilai buku ekuitas:

Nilai Buku saben Saham Agape ATP|ATPC - Pambiji Buku Bisnis|Rasio Nilai Pasar marang Nilai Buku agapeatpgroup.com|ATPC - Gunggung Aset Perusahaan

- rincian struktur utang lan likuiditas bisnis:

Utang marang Ekuitas Agape ATP Corporation|ATPC - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Agape ATP Corp|ATPC - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Agape ATP Corporation|ATPC - Tanggungan jangka dawa|Utang jangka cendhak perusahaan Agape ATP|Likuiditas cepet agapeatpgroup.com

- rincian asil keuangan lan kelipatan valuasi:

ATPC - Bathi sawise pajeg|Proyeksi bathi mangsa ngarep Agape ATP Corporation|ATPC - Kapitalisasi marang bathi|Prakiraan rega marang bathi Agape ATP Corporation|ATPC - Koefisien bali modal nimbang wutah|Pangali EV/EBITDA Agape ATP|ATPC - Bathi operasional EBITDA|Bathi resik saben saham sajrone 12 wulan pungkasan Agape ATP|ATPC - Bathi saben saham sajrone patang kuartal pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan agapeatpgroup.com|ATPC - Dinamika bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Agape ATP Corporation

- indikator volume dodolan lan pendapatan:

ATPC - Pendapatan dodolan perusahaan|Prakiraan volume dodolan Agape ATP Corporation|ATPC - Kapitalisasi marang pendapatan|Rasio rega marang prakiraan pendapatan Agape ATP Corporation

Analisis fundamental perusahaan:agapeatpgroup.com ATPC

Forward P/S relates current market capitalization to expected sales volume, measuring the premium the market is willing to pay per unit of future revenue. For Agape ATP Corporation (ATPC), which is expanding through organic growth in Asia without M&A transactions, the forward P/S metric on GURU.Markets allows for an assessment of how this conservative expansion strategy aligns with market capitalization expectations.

Pesaing utama

Rasio rega marang prakiraan pendapatan ascendispharma.com ASND|Madrigal Corp (MDGL) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|CORT - Rasio rega marang prakiraan pendapatan|RYTM: Rasio rega marang prakiraan pendapatan|AKRO: Multiplikator Forward P/S|MTSR - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan MoonLake Corp|Crinetics Corp (CRNX) - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan newamsterdampharma.com (NAMS)|Multiplikator forward rega marang pendapatan soleno.life SLNO|Multiplikator Forward P/S FOLD (amicusrx.com)|Rasio kapitalisasi marang dodolan sing dikarepake 89bio (ETNB)|Agios - Multiplikator Forward P/S|Structure Corp - Rasio rega marang pendapatan sing dikarepake|mimedx.com (MDXG) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan RZLT (rezolutebio.com)|LXRX (Lexicon Pharmaceuticals Inc) - Multiplikator Forward P/S|Rasio rega marang prakiraan pendapatan MBX|Rasio rega marang prakiraan pendapatan Altimmune Pharma (ALT)|Rasio rega marang prakiraan pendapatan AARD (Aardvark Therapeutics Corp)|Multiplikator Forward P/S SGMT (Sagimet Biosciences, Inc.)|BioAge (BIOA) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|BMEA: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan QNCX (Quince Therapeutics Inc)|GUTS (Fractyl) - Multiplikator forward rega marang pendapatan|vTv Therapeutics, Inc. - Rega forward marang dodolan|PLUR (pluri-biotech.com) - Multiplikator Forward P/S|SYBX: Rega forward marang dodolan|Multiplikator Forward P/S LPCN|Rasio kapitalisasi marang dodolan sing dikarepake Matinas BioPharma Holdings, Inc.|Rasio rega marang prakiraan pendapatan Spruce Biosciences Inc. SPRB|GLTO - Multiplikator forward rega marang pendapatan|CTCX - Rasio rega marang prakiraan pendapatan|LUMO - Multiplikator Forward P/S|ONVO: Multiplikator Forward P/S|RDUS (Radius Recycling) - Rasio rega marang prakiraan pendapatan